SV

Street Verdict

Analyst Scorecard

A record of what Citi Analysis said publicly, with the source. Not advice.

Pending — not yet graded
“Citi is positive on Divi's Laboratories, projecting a significant 43% upside potential. This bullish outlook is likely driven by favorable global regulatory developments and supply-chain realignments benefiting the pharmaceutical sector.”

Citi Analysis’s track record (trackable calls only): 53 graded calls · 95% CI 40–66%

Divi's LaboratoriesBullishCalled 19 Dec 2025
Verdict:PENDING

This call has no verdict yet — it is graded HIT or MISS against real price data once a close decides it. Save it above to find it again from your profile.

Read the original articleSee Citi Analysis’s full track record